Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Capital Employed (2016 - 2026)

Standard Biotools has reported Return on Capital Employed over the past 15 years, most recently at 26.1% for Q4 2025.

  • Quarterly Return on Capital Employed fell 2012.0% to 26.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26.1% through Dec 2025, down 2012.0% year-over-year, with the annual reading at 22.89% for FY2025, 1816.0% down from the prior year.
  • Return on Capital Employed was 26.1% for Q4 2025 at Standard Biotools, down from 2.09% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.63% in Q2 2025 and troughed at 36.97% in Q1 2022.
  • The 5-year median for Return on Capital Employed is 26.1% (2025), against an average of 22.95%.
  • Year-over-year, Return on Capital Employed soared 2855bps in 2024 and then plummeted -2012bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 30.66% in 2021, then fell by -6bps to 32.35% in 2022, then dropped by -7bps to 34.53% in 2023, then soared by 83bps to 5.98% in 2024, then plummeted by -337bps to 26.1% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Capital Employed are 26.1% (Q4 2025), 2.09% (Q3 2025), and 0.63% (Q2 2025).